Hear from 23+ industry experts to help you:

• Enhance prediction capabilities and in turn improve your safety assessment approach with practical lessons on genetic, cardiac and hepatic toxicity testing; insights from AstraZeneca, Bayer, UCB and Lundbeck
• Boost accuracy and reduce late stage drug attrition by capitalising on new technology and techniques including incorporating stem cell models and high content analysis. Exclusive presentations from Pfizer, AstraZeneca, GSK, ReNeuron and Progenitor Labs
• Learn from and benchmark against leading industry case studies on in vitro and in vivo pre-clinical models from Novartis, AstraZeneca and Ferrer Pharmaceuticals
• Accelerate your drug discovery and development and ultimately reduce development cost with a top-down strategic assessment of early discovery drug safety; expert take-home messages from the Drug Safety Executive Council (DSEC) interactive panel discussion
• Modify your interpretations and ultimately ensure compliance by drawing conclusions from the latest research and thinking from the FDA and the EMA’s Committee for Advanced Therapeutics (CAT)

See you in London!

What People Have Said about the Predictive Toxicology Summit

“Overall very valuable, learning about new technology & forming partnerships to move the industry forward”

“An excellent, informative conference as a refresher for current standing in predictive tox”

“Highly valuable and useful”